NCT00918853

Brief Summary

This multicentric prospective study evaluates the role of the margins resection and the ganglionic status when using a quality standard for the resection of adenocarcinoma of the head of the pancreas.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

20 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 11, 2009

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

March 20, 2015

Status Verified

March 1, 2013

Enrollment Period

3.8 years

First QC Date

June 9, 2009

Last Update Submit

March 19, 2015

Conditions

Keywords

pancreasadenocarcinoma

Outcome Measures

Primary Outcomes (1)

  • Prognostic value of the invasion of the margins measured in millimetres on the overall survival

    4 years

Secondary Outcomes (1)

  • Relapse free survival: time between surgery and relapse or a right censure. The relapse is determined by clinical examination, biologic examination and imaging, which reveals metastasis or an isolated local relapse

    4 years

Study Arms (1)

resection for adenocarcinoma

EXPERIMENTAL

quality standard resection for adenocarcinoma of the head of the pancreas

Procedure: resection of adenocarcinoma of the head of the pancreas

Interventions

quality standard for the resection of adenocarcinoma of the head of the pancreas

resection for adenocarcinoma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A head of the pancreas tumor compatible with adenocarcinoma diagnosis
  • tumor apparently removable
  • patient aged from 18 to older
  • signed consent
  • pregnancy, breast feeding
  • patient in an urgency situation or patient with legal protection

You may not qualify if:

  • tumor other than adenocarcinoma of the head of the pancreas.
  • analysis of the margins not done with the defined criteria
  • nonadhesion to the surgical protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Chu D'Angers

Angers, France

Location

Chu de Bordeaux

Bordeaux, France

Location

Hopital Ambroise Pare

Boulogne, France

Location

Chu de Clermont-Ferrand

Clermont-Ferrand, France

Location

Hopital Beaujon

Clichy, France

Location

Hopital Henri Mondor

Créteil, France

Location

Hopital de L'Antiquaille

Lyon, France

Location

Hopital de La Croix-Rousse

Lyon, France

Location

Hospices Civils de Lyon

Lyon, France

Location

Chu La Conception

Marseille, France

Location

Institut Paoli-Calmettes

Marseille, France

Location

Centre Val D'Aurelle Paul Lamarque

Montpellier, France

Location

Hotel Dieu

Nantes, France

Location

Hopital Cochin

Paris, France

Location

Hopital Pitie-Salpetriere

Paris, France

Location

Hopital Tenon

Paris, France

Location

Hopitial Saint Antoine

Paris, France

Location

Hopital Pontchaillou

Rennes, France

Location

Hopitaux Universitaires de Strasbourg

Strasbourg, France

Location

Chu Purpan

Toulouse, France

Location

Related Publications (2)

  • Delpero JR, Jeune F, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, Sauvanet A, Adham M, Autret A, Poizat F, Turrini O, Boher JM. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study. Ann Surg. 2017 Nov;266(5):787-796. doi: 10.1097/SLA.0000000000002432.

  • Delpero JR, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, Sauvanet A, Autret A, Turrini O, Monges-Ranchin G, Boher JM. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB (Oxford). 2014 Jan;16(1):20-33. doi: 10.1111/hpb.12061. Epub 2013 Mar 7.

Related Links

MeSH Terms

Conditions

Adenocarcinoma

Condition Hierarchy (Ancestors)

CarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Jean Robert DELPERO, PhD

    Institut Paoli-Calmettes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2009

First Posted

June 11, 2009

Study Start

August 1, 2008

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

March 20, 2015

Record last verified: 2013-03

Locations